Latest changes
GovPing tracks 302 sources in this role, representing a slice of the 4,020 sources on GovPing, covering guidance, enforcement, rule, FAQ, notice, and consultation content. 894 changes were recorded in the past 7 days.
Recent actions include a $2,000 fine and license revocation for Reymando Fiesta by Hawaii DOH and the summary suspension of Eric Robinson, OD by the New Jersey Optometry Board. The Texas Medical Board also immediately suspended Dr. Giraldi over a public threat, while NH DHHS warned consumers not to eat Dino Nuggets due to unsafe lead levels.
National Institute on Deafness and Other Communication Disorders Notice of Closed Meetings
The National Institutes of Health (NIH) has issued a notice regarding upcoming closed meetings for the National Institute on Deafness and Other Communication Disorders. These meetings are scheduled for April 27, 2026. The notice provides details on the dates of these sessions.
NIH Office of the Director Charter Renewal Notice
The National Institutes of Health (NIH) has published a notice in the Federal Register regarding the renewal of the charter for its Office of the Director. This notice serves to inform the public about the continuation of this advisory committee.
Center for Scientific Review Closed Meetings Notice
The National Institutes of Health (NIH) published a notice regarding upcoming closed meetings for the Center for Scientific Review. These meetings are part of the standard review process for grant applications and do not involve new regulatory requirements.
NIH Strategic Plan Framework FY2027-2031 Request for Comments
The National Institutes of Health (NIH) is seeking public comments on a framework for its agency-wide strategic plan for Fiscal Years 2027-2031. This Request for Information (RFI) aims to gather input to shape the NIH's future research priorities and initiatives.
FDA Delays Effective Date for Beetroot Red Color Additive
The Food and Drug Administration (FDA) has delayed the effective date for the final order concerning the color additive Beetroot Red. The original effective date of February 6, 2026, is now indefinitely postponed, with the FDA to announce a new effective date or further administrative action via a future Federal Register notice.
Spirulina Extract Color Additive Effective Date Delayed
The FDA has delayed the effective date of its final order regarding spirulina extract as a color additive. The original effective date of February 6, 2026, is now indefinitely postponed, with a new effective date to be announced via a future Federal Register publication.
FDA Completeness Assessment Correspondence
The FDA has posted Completeness Assessment Correspondence related to drug applications. This notice indicates that documents are available for review concerning the completeness of certain regulatory submissions.
FDA Complaint Received
The FDA received a complaint on March 23, 2026, related to tobacco products. The complaint document is available for review, though no specific details or actions are provided within the metadata.
FDA Complaint Document
The FDA has posted a complaint document related to its Center for Tobacco Products (CTP). The document is available for review on Regulations.gov, though no specific details about the complaint's content are provided in the metadata.
FDA Complaint Document
The FDA has posted a complaint document authored by CTP. The document is available for download via a link provided on the Regs.gov portal. No further details on the complaint's content or its regulatory implications are provided.
FDA Complaint Document
The FDA has posted a complaint document related to its Center for Tobacco Products (CTP). The document was made available for public comment on March 23, 2026.
FDA Complaint Document
The FDA has posted a complaint document related to tobacco regulation, authored by CTP. This document is part of a public consultation process, with a comment period that has now closed.
Animal Drug User Fees Reporting - Comment Period
The FDA is seeking public comment on proposed information collection provisions related to its animal drug and animal generic drug user fee programs. The comment period is open until May 22, 2026, as required by the Paperwork Reduction Act.
FDA CDER Response Letter to Laboflex, Inc.
The FDA's Center for Drug Evaluation and Research (CDER) has issued a response letter to Laboflex, Inc. The document is a final response, indicating a resolution or specific feedback on a matter concerning the company. No further details on the content or specific regulatory actions are available.
FDA Complaint Document Posted for Comments
The FDA has posted a complaint document related to tobacco products for public comment. The document is available for review and submission of feedback.
FDA Complaint Document
The FDA has posted a complaint document related to its regulatory activities. The document is available for review via the provided URL, with an attachment labeled 'Complaint' authored by CTP.
FDA Complaint Document
The FDA has posted a complaint document related to tobacco product regulations, authored by the Center for Tobacco Products (CTP). This document is open for public comment until March 23, 2026.
FDA Complaint Posted
The FDA has posted a complaint related to tobacco products, authored by CTP. The document was made available on March 23, 2026, and the comment period has closed.
FDA Complaint Document Details
The Food and Drug Administration (FDA) has posted a complaint document related to its regulatory activities. The document is available for review, and the comment period for this specific item has closed.
FDA Complaint Filed and Closed for Comments
The FDA has filed a complaint related to pharmaceutical products, which has now been closed for public comment. The complaint was authored by CTP and is available for review on regulations.gov.
FDA Complaint Filed and Closed for Comments
The FDA has filed a complaint related to tobacco products, which is now open for public comment. The complaint was filed on March 23, 2026, and the comment period is active.
FDA CDER Final Response Letter to Rising Pharma Holdings
The FDA's Center for Drug Evaluation and Research (CDER) has issued a final response letter to Rising Pharma Holdings, Inc. The document details the agency's final decision regarding the company's submission. Specific details of the response are contained within the letter.
FDA Announces Public Hearing on CNPV Pilot Program
The FDA is announcing a public hearing on its Commissioner's National Priority Voucher (CNPV) Pilot Program, designed to expedite review times for qualifying new drug applications and biologics license applications. The agency is seeking feedback on program eligibility, selection processes, and review procedures.
FDA Complaint Document
The FDA has posted a complaint document related to its regulatory activities. The document is available for review on the Regulations.gov portal. No specific compliance actions or deadlines are indicated for regulated entities.
FDA Completeness Assessment Correspondence
The FDA has posted Completeness Assessment Correspondence related to drug applications. This notice indicates that specific correspondence documents are available for review, authored by CDER.
FDA Complaint Filed
The FDA has filed a complaint on March 23, 2026, related to tobacco product regulation. The complaint was authored by the Center for Tobacco Products (CTP). Further details on the specific allegations and parties involved are expected to be available.
FDA Complaint Filed and Closed for Comments
The FDA has filed a complaint related to tobacco products, which is now open for public comment. The complaint was filed on March 23, 2026, and the comment period is ongoing.
FDA Completeness Assessment Correspondence
The FDA has posted Completeness Assessment Correspondence related to drug applications. This notice provides information from the Center for Drug Evaluation and Research (CDER) regarding the completeness of submitted applications.
FDA CDER Final Response Letter to AdventaPharma DWC-LLC
The FDA's Center for Drug Evaluation and Research (CDER) has issued a final response letter to AdventaPharma DWC-LLC. This document is part of the ongoing regulatory process for drug applications and does not appear to contain new compliance obligations.
Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request
The Health Resources and Services Administration (HRSA) is requesting public comment on its plan to submit an information collection request to the Office of Management and Budget (OMB) for review and approval. This pertains to the Bureau of Health Workforce Performance Data Collection, OMB No. 0906-0086.
HRSA Rural Health Care Coordination Program Performance Measures
The Health Resources and Services Administration (HRSA) is proposing new performance measures for the Rural Health Care Coordination Program. This notice requests public comment on the proposed information collection activities, including the title of the collection and the associated OMB control number.
CDC Proposed Data Collection for Public Comment
The Centers for Disease Control and Prevention (CDC) has submitted a proposed data collection for public comment. The comment period is open for 63 days, closing on May 26, 2026. This action allows the public to provide input on the proposed data collection initiative.
CDC: Nominations Sought for Mine Safety Research Advisory Committee
The Centers for Disease Control and Prevention (CDC) is seeking nominations for individuals to serve on the Mine Safety and Health Research Advisory Committee. The notice outlines the nomination process and the deadline for submissions.
Proposed Data Collection for Public Comment
The Centers for Disease Control and Prevention (CDC) has submitted a proposed data collection for public comment. This notice provides instructions and deadlines for submitting feedback on the proposed data collection initiative.
CDC Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has published a notice in the Federal Register regarding agency forms undergoing Paperwork Reduction Act (PRA) review. This notice informs the public about the forms that are subject to PRA review, which is a process to ensure federal agencies do not collect information from the public without appropriate justification and OMB approval.
Virginia Reports 14 Measles Cases in 2026, RHHD Encourages Parents to Schedule Children's Wellness Visits Before Summer
The Richmond and Henrico Health Districts (RHHD) are encouraging families to schedule wellness visits for children with their primary care provider before summer months. As of March 19, 2026, Virginia has reported 14 measles cases, compared to 5 cases in all of 2025. These visits allow children to receive school-required immunizations and physicals before summer travel and activities. The Virginia Vaccines for Children Program (VVFC) provides free or low-cost vaccines for uninsured, underinsured, and Medicaid-enrolled children.
South Carolina Health Planning Committee Meeting Set for March 25
The South Carolina Health Planning Committee will hold its next meeting on Wednesday, March 25, 2026 at 1 p.m. Eastern Time. The meeting will take place at the State of South Carolina Health Campus, Conference Room E169, located at 400 Otarre Parkway in Cayce. A virtual viewing option is available via a link on the meeting event page.
Commission of Hearing Aid Specialists Committee Meeting, March 25, 2026
The South Carolina Department of Public Health announces that the Commission of Hearing Aid Specialists Committee will meet on Wednesday, March 25, 2026 at 10:00 a.m. The meeting will be held at the State of South Carolina Health Campus, Conference Room A141, 400 Otarre Parkway, Cayce. The agenda and virtual viewing link are available on the meeting event page.
South Carolina Health Ranking Improvement
The United Health Foundation's America's Health Rankings 2025 Annual Report shows South Carolina ranking 36th, its highest position since the report's inception in 1990 and an improvement from 41st in 2022. The annual report evaluates 99 health and well-being measures across 31 data sources. South Carolina DPH and the Alliance for a Healthier South Carolina also announced the 2025-2030 State Health Improvement Plan, covering priority areas including chronic health conditions, behavioral health, maternal and infant health, food access, physical activity, healthcare access, income and poverty, education, and community development.
Michigan Launches 2026–2030 Sickle Cell Disease Strategic Plan
MDHHS released its 2026–2030 Sickle Cell Disease Strategic Plan on March 23, 2026, continuing more than a decade of work launched by Michigan's first SCD plan in 2015. The plan outlines six strategic goals focused on system changes, care access, provider education, standards of care, disease-modifying therapies, and data-driven health outcomes. The MDHHS Lifecourse Epidemiology & Genomics Division will lead implementation, with a strategy team convening at least twice annually. The plan builds on expanded Children's Special Health Care Services age eligibility for people with SCD across their lifespan and leverages the Michigan Sickle Cell Data Collection (MiSCDC) Program to track progress and identify gaps.
Boil Water Advisory Issued for City of Thayer, Neosho County, Kansas
KDHE has issued a boil water advisory for the City of Thayer public water supply system in Neosho County, effective March 23, 2026. The advisory was issued following a waterline break that resulted in loss of pressure in the distribution system, creating risk of bacterial contamination from reduced chlorine residuals. The advisory will remain in effect until KDHE rescinds it following laboratory testing confirming the water is safe for consumption.
Louisiana Department of Health Mourns Passing of Former Medicaid Director Ruth Kennedy
The Louisiana Department of Health announced the passing of Ruth Kennedy, former Louisiana Medicaid director, on March 20, 2026. Kennedy dedicated more than 40 years to public service at LDH and played a central role in expanding healthcare access for Louisiana residents, including leading the LaCHIP initiative and overseeing a program serving more than 1 million Louisianans. Her leadership helped transform Louisiana's Medicaid program into a national model for innovation.
USPTO Trademark Application for COILISTRY
The USPTO has received an intent-to-use trademark application for the mark COILISTRY. The application, filed on March 20, 2026, covers cosmetic preparations for hair and scalp, information on education, hair replacement services, and clothing layettes.
USPTO Trademark Publication: Rustic Bronzée
The USPTO has published the trademark application for 'Rustic Bronzée' for spray tanning salon services, initiating a 30-day opposition period. The application was filed on March 21, 2026, and published on March 22, 2026.
MORLIVING Trademark Published for Opposition
The USPTO has published the MORLIVING trademark application for opposition. The application seeks to register the mark for services including personalized healthcare and medical information related to advanced care planning, emergency management, and estate planning. The publication date was March 22, 2026.
USPTO Trademark Application - LASSO for Dietary Supplements
The USPTO has received an intent-to-use trademark application (TM99506083) for the mark 'LASSO'. The application pertains to providing information about dietary supplements and nutrition, specifically for women's health. The filing date was November 19, 2025.
USPTO Trademark Application for Monkey Face Tattoos
The USPTO has received an intent-to-use trademark application for 'Monkey Face Tattoos' for services including tattooing, tattoo studios, and retail sales of tattoo supplies. The application was filed on November 19, 2025.
USPTO Trademark Application for Monkeyface Tattoos
The USPTO has received an intent-to-use trademark application for "MONKEYFACE MONKEYFACETATTOOS" filed on November 19, 2025. The application covers tattooing services, tattoo studios, parlors, and wholesale/retail store services featuring tattoo supplies.
USPTO Trademark Application for Pediatric Occupational Therapy Educational Materials
The USPTO has received a trademark application (TM99505322) for "intent to use" for printed and downloadable educational materials related to pediatric occupational therapy. The application also covers educational services and occupational therapy services.
Boujee Bouquets Trademark Published for Opposition
The USPTO has published the trademark application for 'Boujee Bouquets Floral Wrap Artistry' for opposition. The application, filed on November 17, 2025, covers floral design services featuring floral bouquets. The publication date was March 22, 2026.
Get daily alerts for healthcare compliance
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
910 changes in last 7 days
Latest high priority updates
302 official sources tracked
Related feeds
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Frequently asked questions
What does this feed cover?
CMS transmittals, MLN Matters articles, quality measure updates, HHS OIG work plan changes, HIPAA resolution agreements, Medicaid state plan amendments, and Joint Commission standard updates.
Who is this for?
Healthcare compliance officers, billing managers, and hospital administrators who need to track CMS and HHS changes that affect reimbursement, audits, and patient safety requirements.
How often is this updated?
GovPing checks source pages multiple times daily.
Does this cover Medicaid state plan amendments?
Yes. We monitor CMS Medicaid pages and state plan amendment activity.
Why do CMS transmittals matter?
CMS transmittals change billing rules, coverage determinations, and reimbursement rates. Miss one and your organization could be billing incorrectly for months before an audit catches it.
Is GovPing free?
Yes. GovPing is free, and always will be. We believe government regulatory data should be accessible to everyone. For custom monitoring of pages we don't cover yet, Changeflow starts at $99/mo.
Need to monitor something else?
GovPing covers the common sources. For niche pages specific to your team, add custom URL monitoring with Changeflow.
Get Healthcare Compliance alerts
Daily digest of healthcare compliance regulatory changes. AI-summarized, no noise.
Free. Unsubscribe anytime.